AU2017903033A0 - Bdm-i therapy - Google Patents

Bdm-i therapy

Info

Publication number
AU2017903033A0
AU2017903033A0 AU2017903033A AU2017903033A AU2017903033A0 AU 2017903033 A0 AU2017903033 A0 AU 2017903033A0 AU 2017903033 A AU2017903033 A AU 2017903033A AU 2017903033 A AU2017903033 A AU 2017903033A AU 2017903033 A0 AU2017903033 A0 AU 2017903033A0
Authority
AU
Australia
Prior art keywords
bdm
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017903033A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biodiem Ltd
Original Assignee
Biodiem Ltd
Filing date
Publication date
Application filed by Biodiem Ltd filed Critical Biodiem Ltd
Publication of AU2017903033A0 publication Critical patent/AU2017903033A0/en
Priority to US16/635,600 priority Critical patent/US20200237717A1/en
Priority to CN201880061684.2A priority patent/CN111194213A/en
Priority to PCT/AU2018/050788 priority patent/WO2019023741A1/en
Priority to AU2018310749A priority patent/AU2018310749A1/en
Priority to CA3071577A priority patent/CA3071577A1/en
Priority to EP18841431.2A priority patent/EP3661496A4/en
Abandoned legal-status Critical Current

Links

AU2017903033A 2017-08-01 2017-08-01 Bdm-i therapy Abandoned AU2017903033A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US16/635,600 US20200237717A1 (en) 2017-08-01 2018-07-30 Treatment of Staphylococcal and Enterococcal Infections Using Substituted Nitrostyrene Compounds
CN201880061684.2A CN111194213A (en) 2017-08-01 2018-07-30 Treatment of staphylococcal and enterococcal infections using substituted nitrostyrene compounds
PCT/AU2018/050788 WO2019023741A1 (en) 2017-08-01 2018-07-30 Treatment of staphylococcal and enterococcal infections using substituted nitrostyrene compounds
AU2018310749A AU2018310749A1 (en) 2017-08-01 2018-07-30 Treatment of Staphylococcal and Enterococcal infections using substituted nitrostyrene compounds
CA3071577A CA3071577A1 (en) 2017-08-01 2018-07-30 Treatment of staphylococcal and enterococcal infections using substituted nitrostyrene compounds
EP18841431.2A EP3661496A4 (en) 2017-08-01 2018-07-30 Treatment of staphylococcal and enterococcal infections using substituted nitrostyrene compounds

Publications (1)

Publication Number Publication Date
AU2017903033A0 true AU2017903033A0 (en) 2017-08-10

Family

ID=

Similar Documents

Publication Publication Date Title
EP3463464A4 (en) Combination therapy
EP3551285A4 (en) Defibrillator
EP3732195A4 (en) Cytotoxicity-inducing therapeutic agent
EP3291824A4 (en) Antimicrobial therapy
EP3651772A4 (en) Combination cancer therapy
EP3601536A4 (en) Treatment methods
EP3768258A4 (en) Combination therapy
EP3619238A4 (en) Cytotoxicity-inducing therapeutic agent
EP3515414A4 (en) Combination therapy
EP3413927A4 (en) Cancer therapy
EP3668507A4 (en) Combination therapy
EP3630118A4 (en) Combination therapy
EP3733175A4 (en) Cancer therapeutic
EP3609520A4 (en) Targeted combination therapy
EP3419959A4 (en) Combination therapy
EP3606544A4 (en) Minigene therapy
EP3893874A4 (en) Crenolanib combination therapy
EP3612522A4 (en) Therapeutic compounds
EP3576746A4 (en) Cancer therapeutic
EP3717003A4 (en) Gp96-based cancer therapy
EP3675891A4 (en) Combination cancer therapy
EP3721886A4 (en) Therapeutic method
EP3624849A4 (en) Combination therapy using ascochlorin derivative
EP3655106A4 (en) Combination drug therapy
EP3639835A4 (en) Use ofcimicifugae foetidae